Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 18/20 | 0.55 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.55 |
| ▸ | HTR2A | P28223 | 3/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | ACACB | O00763 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5223064 | 1.00 | MCHR1 (0.55) | MCHR1CHRM1HTR2ACYP2D6ACACB | |
| SCHEMBL6366218 | 0.85 | MCHR1 (0.56) | MCHR1CHRM1HTR2ACYP2D6ACACB | |
| SCHEMBL6365778 | 0.80 | MCHR1 (0.55) | MCHR1CHRM1HTR2ACYP2D6ACACB | |
| SCHEMBL6366223 | 0.80 | MCHR1 (0.55) | MCHR1CHRM1HTR2ACYP2D6ACACB | |
| SCHEMBL6365785 | 0.80 | MCHR1 (0.55) | MCHR1CHRM1HTR2ACYP2D6ACACB | |
| SCHEMBL5226134 | 0.80 | MCHR1 (0.58) | MCHR1CHRM1HTR2ACYP2D6ACACB | |
| SCHEMBL2322959 | 0.80 | MCHR1 (0.58) | MCHR1CHRM1HTR2ACYP2D6ACACB | |
| SCHEMBL5228441 | 0.80 | MCHR1 (0.58) | MCHR1CHRM1HTR2ACYP2D6ACACB | |
| SCHEMBL5230114 | 0.79 | MCHR1 (0.45) | MCHR1CHRM1HTR2ACYP2D6ACACB | |
| SCHEMBL5225511 | 0.79 | MCHR1 (0.45) | MCHR1CHRM1HTR2ACYP2D6ACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1737824-A2 | NOVEL ALKYNE COMPOUNDS HAVING AN MCH-ANTAGONISTIC EFFECT, AND MEDICAMENTS CONTAINING SAID COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-01-03 | — | — | EP | disclosed |
| WO-2005103032-A2 | NOVEL ALKYNE COMPOUNDS HAVING AN MCH-ANTAGONISTIC EFFECT, AND MEDICAMENTS CONTAINING SAID COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-11-03 | — | — | WO | disclosed |